IBDEI2JV ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42765,1,3,0)
 ;;=3^Phlebitis & Thromboph,Left Femoral Vein
 ;;^UTILITY(U,$J,358.3,42765,1,4,0)
 ;;=4^I80.12
 ;;^UTILITY(U,$J,358.3,42765,2)
 ;;=^5007826
 ;;^UTILITY(U,$J,358.3,42766,0)
 ;;=I80.13^^192^2145^3
 ;;^UTILITY(U,$J,358.3,42766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42766,1,3,0)
 ;;=3^Phlebitis & Thromboph,Bilateral Femora Vein
 ;;^UTILITY(U,$J,358.3,42766,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,42766,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,42767,0)
 ;;=L98.0^^192^2145^21
 ;;^UTILITY(U,$J,358.3,42767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42767,1,3,0)
 ;;=3^Pyogenic granuloma
 ;;^UTILITY(U,$J,358.3,42767,1,4,0)
 ;;=4^L98.0
 ;;^UTILITY(U,$J,358.3,42767,2)
 ;;=^5009574
 ;;^UTILITY(U,$J,358.3,42768,0)
 ;;=L40.0^^192^2145^16
 ;;^UTILITY(U,$J,358.3,42768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42768,1,3,0)
 ;;=3^Psoriasis vulgaris
 ;;^UTILITY(U,$J,358.3,42768,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,42768,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,42769,0)
 ;;=L40.1^^192^2145^19
 ;;^UTILITY(U,$J,358.3,42769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42769,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,42769,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,42769,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,42770,0)
 ;;=L40.9^^192^2145^17
 ;;^UTILITY(U,$J,358.3,42770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42770,1,3,0)
 ;;=3^Psoriasis, unspec
 ;;^UTILITY(U,$J,358.3,42770,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,42770,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,42771,0)
 ;;=L40.3^^192^2145^20
 ;;^UTILITY(U,$J,358.3,42771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42771,1,3,0)
 ;;=3^Pustulosis palmaris et plantaris
 ;;^UTILITY(U,$J,358.3,42771,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,42771,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,42772,0)
 ;;=L40.8^^192^2145^15
 ;;^UTILITY(U,$J,358.3,42772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42772,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,42772,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,42772,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,42773,0)
 ;;=L40.4^^192^2145^18
 ;;^UTILITY(U,$J,358.3,42773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42773,1,3,0)
 ;;=3^Psoriasis,Guttate
 ;;^UTILITY(U,$J,358.3,42773,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,42773,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,42774,0)
 ;;=M72.2^^192^2145^9
 ;;^UTILITY(U,$J,358.3,42774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42774,1,3,0)
 ;;=3^Plantar fascial fibromatosis
 ;;^UTILITY(U,$J,358.3,42774,1,4,0)
 ;;=4^M72.2
 ;;^UTILITY(U,$J,358.3,42774,2)
 ;;=^272598
 ;;^UTILITY(U,$J,358.3,42775,0)
 ;;=M15.9^^192^2145^10
 ;;^UTILITY(U,$J,358.3,42775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42775,1,3,0)
 ;;=3^Polyosteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,42775,1,4,0)
 ;;=4^M15.9
 ;;^UTILITY(U,$J,358.3,42775,2)
 ;;=^5010768
 ;;^UTILITY(U,$J,358.3,42776,0)
 ;;=I87.002^^192^2145^13
 ;;^UTILITY(U,$J,358.3,42776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42776,1,3,0)
 ;;=3^Postthrom syndr w/o compl of lft lwr extrem
 ;;^UTILITY(U,$J,358.3,42776,1,4,0)
 ;;=4^I87.002
 ;;^UTILITY(U,$J,358.3,42776,2)
 ;;=^5008028
 ;;^UTILITY(U,$J,358.3,42777,0)
 ;;=I73.9^^192^2145^2
 ;;^UTILITY(U,$J,358.3,42777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42777,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,42777,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,42777,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,42778,0)
 ;;=M06.372^^192^2146^12
 ;;^UTILITY(U,$J,358.3,42778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42778,1,3,0)
 ;;=3^Rheumatoid nodule, left Ankle/Foot
